X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
endocrinology & metabolism (17) 17
original (17) 17
index medicus (15) 15
original article (15) 15
type 2 diabetes (15) 15
humans (12) 12
male (11) 11
sitagliptin (11) 11
middle aged (10) 10
female (9) 9
diabetes (8) 8
dipeptidyl peptidase-4 inhibitor (8) 8
insulin (8) 8
aged (7) 7
diabetes mellitus, type 2 - drug therapy (7) 7
hba1c (7) 7
mellitus (7) 7
body weight (6) 6
diabetes mellitus (6) 6
glycated hemoglobin a - metabolism (6) 6
glycemic control (6) 6
glycosylated hemoglobin (6) 6
japan (6) 6
type 2 diabetes mellitus (6) 6
articles (5) 5
classification (5) 5
diabetes mellitus, type 2 - blood (5) 5
diabetes therapy (5) 5
hemoglobin a1c (5) 5
hypoglycemia (5) 5
hypoglycemic agents - therapeutic use (5) 5
management (5) 5
medical research (5) 5
nutritional and metabolic diseases (5) 5
therapy (5) 5
adult (4) 4
care and treatment (4) 4
clinical science and care (4) 4
diabetes mellitus, type 2 - metabolism (4) 4
dipeptidyl-peptidase iv inhibitors - therapeutic use (4) 4
drug therapy, combination (4) 4
endocrine system diseases (4) 4
glucose (4) 4
hypoglycemic agents (4) 4
insulin resistance (4) 4
ipragliflozin (4) 4
medicine, experimental (4) 4
sulfonylurea (4) 4
treatment outcome (4) 4
analysis (3) 3
animals (3) 3
body mass index (3) 3
cholesterol (3) 3
complications (3) 3
diabetics (3) 3
double-blind (3) 3
dpp-4 inhibitor (3) 3
endocrinology (3) 3
general practitioner (3) 3
glucagon - metabolism (3) 3
glucose metabolism (3) 3
insulin - metabolism (3) 3
insulin secretion (3) 3
japan - epidemiology (3) 3
medicine & public health (3) 3
metformin (3) 3
original research (3) 3
physicians (3) 3
prevalence (3) 3
retrospective studies (3) 3
safety (3) 3
type-2 diabetes-mellitus (3) 3
aged, 80 and over (2) 2
asia (2) 2
blood glucose (2) 2
blood glucose - metabolism (2) 2
blood pressure (2) 2
body composition (2) 2
body fat mass (2) 2
care (2) 2
cross-sectional studies (2) 2
cross-sectional survey (2) 2
dextrose (2) 2
diabetes mellitus - blood (2) 2
diagnosis (2) 2
dpp‐4 inhibitor (2) 2
efficacy (2) 2
endocrinology, diabetes and metabolism (2) 2
fatty acids (2) 2
glucose clamp technique (2) 2
glycated hemoglobin a - analysis (2) 2
hypoglycemia - chemically induced (2) 2
incretin (2) 2
insulin - therapeutic use (2) 2
insulin sensitivity (2) 2
insulin-dependent diabetes mellitus (2) 2
islets of langerhans - metabolism (2) 2
japanese patients (2) 2
liraglutide (2) 2
liver (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes, Obesity and Metabolism, ISSN 1462-8902, 05/2018, Volume 20, Issue 5, pp. 1311 - 1315
The impact of tofogliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on peripheral glucose uptake in patients with type 2 diabetes mellitus (T2DM) was... 
body composition | DPP‐4 inhibitor | type 2 diabetes | insulin resistance | DPP-4 inhibitor | THERAPY | ENDOCRINOLOGY & METABOLISM | MUSCLE | TYPE-2 DIABETES-MELLITUS | ENDOGENOUS GLUCOSE-PRODUCTION | Glycated Hemoglobin A - analysis | Overweight - complications | Overweight - drug therapy | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Anti-Obesity Agents - adverse effects | Diabetes Mellitus, Type 2 - metabolism | Weight Loss - drug effects | Anti-Obesity Agents - therapeutic use | Hypoglycemia - prevention & control | Overweight - metabolism | Drug Therapy, Combination - adverse effects | Benzhydryl Compounds - adverse effects | Glucosides - therapeutic use | Hypoglycemia - chemically induced | Benzhydryl Compounds - therapeutic use | Diabetes Mellitus, Type 2 - complications | Glucosides - adverse effects | Body Mass Index | Hyperglycemia - prevention & control | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Adiposity - drug effects | Sodium-Glucose Transporter 2 Inhibitors - adverse effects | Blood Glucose - analysis | Insulin Resistance | Biomarkers - blood | Electric Impedance | Diabetes Mellitus, Type 2 - blood | Overweight - blood | Glucose Clamp Technique | Diabetes Mellitus, Type 2 - drug therapy | Type 2 diabetes | Glucose metabolism | Liver | Body weight | Glycosylated hemoglobin | Insulin resistance | Glucose | Dextrose | Glucose transporter | Peptidase | Body fat | Diabetes mellitus | Insulin | Patients | Body composition | Body mass | Sodium | Hemoglobin | Lean body mass | Blood pressure | Lipid metabolism | Diabetes mellitus (non-insulin dependent) | Index Medicus | Brief Report | Brief Reports
Journal Article
Journal Article
Journal Article
Journal of Diabetes Investigation, ISSN 2040-1116, 11/2018, Volume 9, Issue 6, p. 1323
Pemafibrate is a novel selective peroxisome proliferator-activated receptor-[alpha] modulator with potent triglyceride-lowering and high-density lipoprotein... 
Glucose metabolism | Medical research | Care and treatment | Hyperlipidemia | Analysis | Medicine, Experimental | Insulin resistance | Fibroblast growth factors | Triglycerides | Glucose | Fatty acids | Dextrose
Journal Article
BMC Endocrine Disorders, ISSN 1472-6823, 09/2015, Volume 15, Issue 1, pp. 46 - 46
Journal Article
DIABETES CARE, ISSN 0149-5992, 09/2012, Volume 35, Issue 9, pp. 1853 - 1857
OBJECTIVE-To investigate the relationship between fasting insulin levels and metabolic risk factors (MRFs) in type 2 diabetic patients at the first... 
CHOLESTEROL | ENDOCRINOLOGY & METABOLISM | SENSITIVITY | CLASSIFICATION | MELLITUS | MODEL | PREVALENCE | SECRETION | PROJECTIONS | GLUCOSE-TOLERANCE | NIDDM
Journal Article
Journal of Diabetes Investigation, ISSN 2040-1116, 07/2014, Volume 5, Issue 4, pp. 445 - 448
We analyzed the changes of glycemic control over 12 months and the factors influencing blood glucose in 162 Japanese patients with type 2 diabetes having... 
Blood glucose | Sitagliptin | Sulfonylurea | METFORMIN | DIPEPTIDYL PEPTIDASE-4 INHIBITOR | EFFICACY | SAFETY | INSULIN SENSITIVITY | GLYBURIDE MONOTHERAPY | GLICLAZIDE | CELL FUNCTION | ENDOCRINOLOGY & METABOLISM | JAPANESE PATIENTS | TYPE-2 DIABETES-MELLITUS | Glucose metabolism | Hypoglycemic agents | Blood sugar | Analysis | Hypoglycemia | Glucose | Short Report
Journal Article
Journal of clinical medicine research, ISSN 1918-3003, 06/2013, Volume 5, Issue 3, pp. 217 - 221
Several studies have shown the effectiveness of sitagliptin, a dipeptidyl peptidase-4 inhibitor, for type 2 diabetes, with a hypoglycemic effect being... 
Type 2 diabetes | Sitagliptin | Hemoglobin A1c | Long-term administration | Original
Journal Article
Endocrine Journal, ISSN 0918-8959, 2010, Volume 57, Issue 6, pp. 499 - 507
Sulfonylureas are commonly used for the treatment of patients with type 2 diabetes mellitus (T2DM). However, some clinical concerns regarding their use have... 
T2DM | General practitioner | HbA1c | Sulfonylurea | Cross-sectional survey | GLYCEMIC CONTROL | INSULIN-SECRETION | CLASSIFICATION | MELLITUS | BODY-WEIGHT | ENDOCRINOLOGY & METABOLISM | COMPLICATIONS | GLIMEPIRIDE | BLOOD-GLUCOSE CONTROL | Index Medicus
Journal Article
Diabetology International, ISSN 2190-1678, 6/2013, Volume 4, Issue 2, pp. 101 - 105
To (1) measure urinary albumin and estimated glomerular filtration rate (eGFR) in patients with type 2 diabetes mellitus (DM) in Kanagawa Prefecture, (2)... 
Type 2 diabetes | Renal function | Medicine & Public Health | Metabolic Diseases | Classification | Diabetic nephropathy | Chronic kidney disease | Diabetes | Endocrinology
Journal Article
Journal Article
Journal of clinical medicine research, ISSN 1918-3003, 03/2017, Volume 9, Issue 3, pp. 188 - 192
The influence of long-term sitagliptin therapy on office blood pressure (BP) and home BP has been unclear. In a retrospective cohort study of 454 patients with... 
Hypertension | Home blood pressure | Dipeptidyl peptidase-4 inhibitor | Original | Pleiotropic effect | Diabetes mellitus
Journal Article
Journal of Diabetes Investigation, ISSN 2040-1116, 08/2012, Volume 3, Issue 4, pp. 396 - 401
Aims/Introduction:  Insulin therapy is often required to achieve good glycemic control in patients with type 2 diabetes mellitus. However, some providers,... 
General practitioner | Insulin therapy | Type 2 diabetes mellitus | GLYCEMIC CONTROL | MANAGEMENT | ASPART | ENDOCRINOLOGY & METABOLISM | RANDOMIZED-TRIAL | CLASSIFICATION | COMPLICATIONS | MELLITUS | PROGRESSION | Surveys | Type 2 diabetes | Medical colleges | Glycosylated hemoglobin | Physicians (General practice) | Insulin | Diabetes therapy | Original
Journal Article